Pharmaceutical Filtration Market Size, Share, Industry, Forecast and outlook (2023-2030)
Pharmaceutical Filtration Market is segmented By Product (Membrane Filters, Prefilter & Depth Filter Media, Single-Use Systems, Catriage & Capsules, Filter Holders, Filteration Accessories, Other), By Application (Final Product Processing, Raw Material Filtration, Cell Separation, Water Purification, Air Purification), By Technique Type (Microfiltration, Ultrafiltration, Nanofiltration, Others), By End User (Pharmaceutical, Biotechnology, Contract Manufacturing Organization, Others), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2022-2029.
Pharmaceutical filtration market size was valued at US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 12.1% during the forecast period (2022-2029).
Pharmaceutical filtration is a separation method that involves putting processed materials through a filtration membrane to remove undesired particles. This filtration method aids in the separation of suspended particles from a solution or medium. The pharmaceutical production business provides extensive and considerable sterile and nonsterile filtering of products. Filters also remove pollutants from solids, air, liquids, and gases, such as particulate matter and bacteria. Pharmaceutical filtration techniques are also commonly employed in various applications, including final product processing, water purification, raw material filtration, cell separation, and air purification.
Asia-Pacific region holds the largest market share of the global pharmaceutical filtration market
Due to increased demand for pharmaceutical filtration products and increased investment in the pharmaceutical and biopharmaceutical industries, Asia-Pacific presents lucrative opportunities for key players in the pharmaceutical filtration market. Furthermore, advancements in healthcare infrastructure, an increase in the prevalence of diseases such as malaria, polio, and rabies, a developing R&D sector, an increase in healthcare reforms, and technological advancements in the field of healthcare all contribute to market growth. Other factors such as the increased focus of leading manufacturers on expanding their geographic presence in emerging Asia-Pacific countries to capture high growth opportunities in the market and a large population base are expected to boost the growth of the Asia-Pacific pharmaceutical filtration market.
Furthermore, organic and inorganic tactics within key market players, such as mergers and acquisitions and alliances, would strengthen their product range in the studied industry, driving the market. In addition, multiple product releases will result in profitable market expansion.. For instance, in August 2021, Amazon Filters has introduced a new line of filter housings, the single-stack 72C and 76C series, to aid critical processes in the biopharmaceutical manufacturing process. Furthermore, advancements in various surgical devices from established key players, in the Asia-Pacific, are likely to drive the market growth in Asia Pacific region.
Pharmaceutical Filtration Market Scope
Metrics |
Details |
Market CAGR |
12.1% |
Segments Covered |
By Product, By Application, By End User, and By Region |
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
Regions Analyzed |
North America, Latin America, Europe, Middle East, Africa, Asia Pacific, and the Rest of the world. |
Major Companies Covered |
FzioMed, Inc., Amniox Medical, Inc., Human Regenerative Technologies, LLC, Amnio Technology, LLC, Derma Sciences, MiMedx Group, Inc, and among other major companies listed in the full report |
Pharmaceutical Filtration Market Dynamics
The rise in demand for therapeutic biopharmaceuticals such as hormones, antibodies, and vaccines; technological advancements in nanofiltration technology; surge in demand for single-use technologies; rise in R&D spending due to rise in government healthcare expenditure, and increase in the number of pharmaceutical and biopharmaceutical companies worldwide are some of the factors driving the growth of the pharmaceutical filtration market.
Increased production of biologics and large molecules will drive the market growth
Biopharmaceuticals are one of the fastest-growing segments; filtration is widely used in the biopharmaceuticals industry. According to QuintilesIMS, global pharmaceutical spending will have increased by nearly USD 1.4 trillion by 2023. The global pharmaceutical market's share of biopharmaceutical products is expected to rise from 23% in 2014 to 27% in 2023. The increasing use of cell therapy, gene therapy, and recombinant therapeutics to treat various diseases and disorders such as rheumatoid arthritis, diabetes, and cancer can be attributed to the growing share. According to the Tufts Center for the Study of Drug Development, biotech products accounted for 71% of the top ten products' revenue in 2012. Furthermore, the looming patent cliff and the efficacy of biologics are compelling most pharmaceutical companies to develop new biologics. This leads to increased adoption of filtration methods for biologics manufacturing, resulting in market growth.
Moreover ,a significant increase in the number of generic drug launches; an increase in demand for therapeutic biopharmaceuticals such as hormones, antibodies, and vaccines; technological advancements in nanofiltration technology; an increase in demand for single-use technologies; an increase in R&D spending due to an increase in government healthcare expenditure; and an increasing number of pharmaceutical and biopharmaceutical companies worldwide are some of the factors boosting the growth of the industry. Furthermore, the rise in chronic disease prevalence, strong biologic pipeline products, and increased demand for filters in the pharmaceutical and biopharmaceutical industries drive the pharmaceutical filtration market growth. Furthermore, pharmaceutical filters' advantages such as low operating pressure, high speed, and low energy consumption fuel the market growth.
Strict government regulations for the validation of filtration processes is likely to hamper the market growth
Obtaining FDA approval for new and innovative products is difficult for pharmaceutical and biotechnology companies. Validation of filtering procedures helps to guarantee that the process runs smoothly and consistently. The FDA provides Quality by Design (QbD) principles in the United States, used to design the filtration process. This proves that pharmacological filters are effective. Health Canada uses GMP rules to regulate pharmaceutical filters in Canada. The Parenteral Drug Association (PDA) (United States) compiles technical data on validations or equipment qualification, process development, process validation, cleaning validation, and membrane reuse of pharmaceutical filtering equipment worldwide.
COVID-19 Impact Analysis
Millions of people, businesses, and healthcare providers are affected by the novel COVID 19 virus created by the SARS-COV-2 agent. From March to May, the governments maintained a strict curfew. Many pharmaceutical and biotechnology companies have temporarily closed their doors due to a labor shortage to avert widespread sickness. The pandemic's impact on the pharmaceutical filtration market has been good. Filtration methods are critical in dealing with the effects of COVID 19. During the COVID 19 pandemic lockdown, most pharmaceutical filtration firms around the world halted operations. During the pandemic, demand for these filtering devices has increased. The rise is attributed to ongoing vaccine research and development to help virus-infected people recover. The threat of COVID 19 transmission by air in interior areas are driving the pharmaceutical filtration sector. The Nanotech filter coats air filters to catch virus droplets in the air. The demand for this market is increasing as the purity improves.
Pharmaceutical Filtration Market Segment Analysis
The microfiltration segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)
The microfiltration process is the most profitable. One of the segment's main driving forces in product development. Merck KGaA, for example, introduced Viresolve Pro Shield H in 2016, which is designed to eliminate parvoviruses from therapeutic protein feed streams. Manufacturers frequently employ this approach to separate big particles such as proteins and yeast from a liquid feed stream.
Microfiltration is used in the pharmaceutical industry for clarification, purification of cell broths, separation of cell debris, and separation of macromolecules. The technique is used in upstream bioprocessing to harvest cells. It is used in the fermentation process to recover and purify biomass during the production of antibiotics. The technique makes enzyme concentrations before other processes in industrial enzyme production lines.The filtration of aqueous solutions—the treatment of drinking and beverage water—is the most important application of microfiltration. Its higher adoption over other methods is attributed to its broad pharmaceutical applications, contributing to the market's growth.
Pharmaceutical Filtration Market Competitive Landscape
The pharmaceutical filtration market is a highly competitive presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include 3 M Company, Amazon Filters Ltd, Eaton Corporation Plc, GE Healthcare, Graver Technologies LLC, Meissner Filtration Products Inc, Merck & Co, Parker –Hannifin Corporation, Sartorius Stedim Biotech SA among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the pharmaceutical filtration market globally. For instance, In May 2021, A US federal agency, BARDA, awarded Meissner a contract for roughly USD 13.4 million to boost production capacity for vaccination and therapy components. Single-use systems for filtration, filling assemblies, bottle assemblies, and bio container assemblies, among other things, would be manufactured by the company.
Key Developments
In January 2022, The new SupralonTM Filter Element from Pall Corporation improves equipment protection while lowering energy costs.
Meissner Filtration Products
Overview:
Meissner is a company that makes advanced microfiltration and single-use systems. We leverage our R&D efforts to provide our clients with products that deliver advanced processing and fluid handling solutions for pharmaceutical and biopharmaceutical manufacturing.
Product Portfolio:
SepraPor: SepraPor is a tangential flow filtration device that uses microporous hollow fiber membranes (HFM). SepraPor devices are ideal for bacterial cell concentration, mammalian cell concentration, yeast concentration, and continuous cell culture perfusion. SepraPor® filters come in various sizes and formats, including capsules and cartridges. Cartridges are designed to fit inside stainless steel housings for sterilization and operation using steam-in-place (SIP). Capsules can be purchased as standalone filters or as part of process-ready, gamma-sterilized assemblies. Both capsule and cartridge filters are built to withstand autoclave, SIP, or gamma sterilization.
Frequently Asked Questions
What is the Projected CAGR value of the Pharmaceutical Filtration Market?
Pharmaceutical Filtration Market is expected to grow at a CAGR of 12.1% during the forecasting period 2022-2029.
Which region controlled the global market during 2022-2029?
North America region Controls the Pharmaceutical Filtration Market during 2022-2029
Which is the fastest growing region in the Pharmaceutical Filtration Market?
Among all regions, Asia Pacific is the fastest growing market share during the forecast period.